As of April 16, 2025, Aquestive Therapeutics (AQST) has a market cap of $0.25 billion USD. According to our data, Aquestive Therapeutics is ranked No.6718 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.25 B |
-21.72%
|
Dec 31, 2024 | $0.32 B |
76.24%
|
Dec 29, 2023 | $0.18 B |
123.95%
|
Dec 30, 2022 | $82.24 M |
-76.81%
|
Dec 31, 2021 | $0.35 B |
-27.29%
|
Dec 31, 2020 | $0.49 B |
-8.08%
|
Dec 31, 2019 | $0.53 B |
-7.62%
|
Dec 31, 2018 | $0.57 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Alkermes
ALKS
|
$4.61 B |
-0.000 M
|
![]() Ireland
|
![]() Ono Pharmaceutical
4528.T
|
$5.63 B |
-0.013 B
|
![]() Japan
|
![]() Biogen
BIIB
|
$17.12 B |
0.000 M
|
![]() USA
|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Teva Pharmaceutical Industries
TEVA
|
$15.60 B |
0.000 M
|
![]() Israel
|
![]() Stryker Corporation
SYK
|
$132.37 B |
-0.002 M
|
![]() USA
|
![]() Neurocrine Biosciences
NBIX
|
$9.51 B |
0.000 M
|
![]() USA
|
![]() Novartis
NVS
|
$217.12 B |
0.003 M
|
![]() Switzerland
|
![]() Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
![]() USA
|
![]() Sanofi
SNY
|
$123.58 B |
-0.002 M
|
![]() France
|
![]() Merck
MRK
|
$197.26 B |
0.003 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
Market Cap | = | AQST Stock Price | * | AQST Shares Outstanding |
= | $2.57 | * | 98.87 M | |
= | $0.25 B |